Logo image of XPER

XPERI INC (XPER) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:XPER - US98423J1016 - Common Stock

5.87 USD
-0.06 (-1.01%)
Last: 12/29/2025, 6:30:00 PM
5.87 USD
0 (0%)
After Hours: 12/29/2025, 6:30:00 PM
Fundamental Rating

4

Taking everything into account, XPER scores 4 out of 10 in our fundamental rating. XPER was compared to 276 industry peers in the Software industry. XPER scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XPER is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

XPER had positive earnings in the past year.
XPER had a negative operating cash flow in the past year.
In the past 5 years XPER always reported negative net income.
XPER had negative operating cash flow in 4 of the past 5 years.
XPER Yearly Net Income VS EBIT VS OCF VS FCFXPER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

XPER's Return On Assets of 1.11% is fine compared to the rest of the industry. XPER outperforms 60.14% of its industry peers.
Looking at the Return On Equity, with a value of 1.65%, XPER is in the better half of the industry, outperforming 61.96% of the companies in the same industry.
Industry RankSector Rank
ROA 1.11%
ROE 1.65%
ROIC N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
XPER Yearly ROA, ROE, ROICXPER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

XPER's Profit Margin of 1.53% is fine compared to the rest of the industry. XPER outperforms 60.14% of its industry peers.
XPER has a Gross Margin of 73.61%. This is in the better half of the industry: XPER outperforms 60.14% of its industry peers.
In the last couple of years the Gross Margin of XPER has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 1.53%
GM 73.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
XPER Yearly Profit, Operating, Gross MarginsXPER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

4

2. Health

2.1 Basic Checks

XPER does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XPER has been increased compared to 1 year ago.
XPER has less shares outstanding than it did 5 years ago.
XPER has a worse debt/assets ratio than last year.
XPER Yearly Shares OutstandingXPER Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
XPER Yearly Total Debt VS Total AssetsXPER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.35, we must say that XPER is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.35, XPER is doing worse than 73.91% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that XPER is not too dependend on debt financing.
XPER has a Debt to Equity ratio (0.10) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -0.35
ROIC/WACCN/A
WACC10.87%
XPER Yearly LT Debt VS Equity VS FCFXPER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

XPER has a Current Ratio of 2.42. This indicates that XPER is financially healthy and has no problem in meeting its short term obligations.
XPER has a Current ratio of 2.42. This is in the better half of the industry: XPER outperforms 67.39% of its industry peers.
A Quick Ratio of 2.42 indicates that XPER has no problem at all paying its short term obligations.
The Quick ratio of XPER (2.42) is better than 68.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 2.42
XPER Yearly Current Assets VS Current LiabilitesXPER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.23% over the past year.
The earnings per share for XPER have been decreasing by -21.24% on average. This is quite bad
The Revenue for XPER has decreased by -10.74% in the past year. This is quite bad
Measured over the past years, XPER shows a very strong growth in Revenue. The Revenue has been growing by 20.04% on average per year.
EPS 1Y (TTM)36.23%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%-45.1%
Revenue 1Y (TTM)-10.74%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-16%

3.2 Future

Based on estimates for the next years, XPER will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.43% on average per year.
XPER is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.14% yearly.
EPS Next Y-23.95%
EPS Next 2Y1.59%
EPS Next 3Y17.43%
EPS Next 5YN/A
Revenue Next Year-10%
Revenue Next 2Y-2.47%
Revenue Next 3Y2.18%
Revenue Next 5Y7.14%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XPER Yearly Revenue VS EstimatesXPER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
XPER Yearly EPS VS EstimatesXPER Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.24 indicates a rather cheap valuation of XPER.
Based on the Price/Earnings ratio, XPER is valued cheaper than 93.12% of the companies in the same industry.
XPER's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.84.
The Price/Forward Earnings ratio is 5.86, which indicates a rather cheap valuation of XPER.
Based on the Price/Forward Earnings ratio, XPER is valued cheaper than 94.20% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.40, XPER is valued rather cheaply.
Industry RankSector Rank
PE 6.24
Fwd PE 5.86
XPER Price Earnings VS Forward Price EarningsXPER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

XPER's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. XPER is cheaper than 72.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.56
XPER Per share dataXPER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

XPER's earnings are expected to grow with 17.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.59%
EPS Next 3Y17.43%

0

5. Dividend

5.1 Amount

XPER does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

XPERI INC

NYSE:XPER (12/29/2025, 6:30:00 PM)

After market: 5.87 0 (0%)

5.87

-0.06 (-1.01%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-26 2026-02-26/amc
Inst Owners91.5%
Inst Owner Change-1.92%
Ins Owners3.06%
Ins Owner Change-0.54%
Market Cap272.02M
Revenue(TTM)453.96M
Net Income(TTM)6.96M
Analysts81.82
Price Target11.63 (98.13%)
Short Float %5.1%
Short Ratio4.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.63%
Min EPS beat(2)13.91%
Max EPS beat(2)31.34%
EPS beat(4)4
Avg EPS beat(4)180.36%
Min EPS beat(4)13.91%
Max EPS beat(4)613.01%
EPS beat(8)8
Avg EPS beat(8)191.78%
EPS beat(12)12
Avg EPS beat(12)151.91%
EPS beat(16)15
Avg EPS beat(16)118.82%
Revenue beat(2)1
Avg Revenue beat(2)-3.76%
Min Revenue beat(2)-8.36%
Max Revenue beat(2)0.84%
Revenue beat(4)1
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-8.36%
Max Revenue beat(4)0.84%
Revenue beat(8)1
Avg Revenue beat(8)-3.05%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)2
Avg Revenue beat(16)-10.95%
PT rev (1m)0%
PT rev (3m)3.64%
EPS NQ rev (1m)-9.77%
EPS NQ rev (3m)-33.64%
EPS NY rev (1m)-2.83%
EPS NY rev (3m)-2.83%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-4.13%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 6.24
Fwd PE 5.86
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.96
EV/EBITDA 26.56
EPS(TTM)0.94
EY16.01%
EPS(NY)1
Fwd EY17.06%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS9.8
BVpS9.09
TBVpS6.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.86
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 1.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.53%
GM 73.61%
FCFM N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
F-Score4
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 4.87
Cap/Depr 37.93%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.42
Quick Ratio 2.42
Altman-Z -0.35
F-Score4
WACC10.87%
ROIC/WACCN/A
Cap/Depr(3y)21.67%
Cap/Depr(5y)15.65%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.23%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%-45.1%
EPS Next Y-23.95%
EPS Next 2Y1.59%
EPS Next 3Y17.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.74%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-16%
Revenue Next Year-10%
Revenue Next 2Y-2.47%
Revenue Next 3Y2.18%
Revenue Next 5Y7.14%
EBIT growth 1Y59.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year631.37%
EBIT Next 3Y119.05%
EBIT Next 5Y75.21%
FCF growth 1Y56.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.02%
OCF growth 3YN/A
OCF growth 5YN/A

XPERI INC / XPER FAQ

What is the fundamental rating for XPER stock?

ChartMill assigns a fundamental rating of 4 / 10 to XPER.


Can you provide the valuation status for XPERI INC?

ChartMill assigns a valuation rating of 6 / 10 to XPERI INC (XPER). This can be considered as Fairly Valued.


What is the profitability of XPER stock?

XPERI INC (XPER) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for XPER stock?

The Price/Earnings (PE) ratio for XPERI INC (XPER) is 6.24 and the Price/Book (PB) ratio is 0.65.


What is the expected EPS growth for XPERI INC (XPER) stock?

The Earnings per Share (EPS) of XPERI INC (XPER) is expected to decline by -23.95% in the next year.